Company
InnoDrug Lab. (Hongkong) Co., Ltd was founded by Prof. Yi Zhun ZHU, a Singaporean attracted by the ‘talented program’ by the HK government, who has the rich experience for the drug discovery. He was reported by the most influential scientific magazine Science to be one of the most successful returnee scientists and well-known news magazine in Pharmaceutical industry C&EN as pioneer for drug discovery: he shepherded the development of a cardiovascular drug candidate, leonurine, from discovery to the completion of preclinical studies.
